EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs

Tatsuya Iwasaki iD, Koji Akeda iD, Koki Kawaguchi, Junichi Yamada iD, Takahiro Hasegawa, Norihiko Takegami, Tatsuhiko Fujiwara, Akihiro Sudo

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tatsuya Iwasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City 514-8507, Mie, Japan. Hauptthemen laut MEDLINE: Glial Cell Line-Derived Neurotrophic Factor, Intervertebral Disc. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glial-cell-line-derived neurotrophic factor (GDNF) family ligands (GFLs) contribute to the sensitization of primary afferents and are involved in the pathogenesis of inflammatory pain. The purpose of this preliminary study was to examine the expression of other GFLs (neurturin (NRTN), artemin (ARTN), persephin (PSPN)) and receptors in human IVD cells and tissues exhibiting early and advanced stages of degeneration. Human IVD cells were cultured as a monolayer after isolation from the nucleus pulposus (NP) and anulus fibrosus (AF) tissues. The mRNA expression of NRTN, ARTN, PSPN, and their receptors (GFRA2–GFRA4) was quantified using real-time PCR. Protein expression was evaluated using immunohistochemistry and Western blotting. The expression of NRTN, ARTN, PSPN, and their co-receptors (GFRA2-GFRA4) was identified in human IVD cells at both mRNA and protein levels. A trend was noted wherein the mRNA expression of ARTN, PSPN, and GFRA2 was upregulated by IL-1β treatment in a dose-dependent manner. The percentages of immunopositive cells in the advanced degenerate stage of ARTN, PSPN, and GFRA2 were significantly higher than those in the early degenerate stage. Their expression was enhanced in advanced tissue degeneration, which suggests that GFLs (ARTN and PSPN) may be involved in the pathogenesis of discogenic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glial Cell Line-Derived Neurotrophic FactorIntervertebral DiscHumansTransforming Growth Factor betaRNA, MessengerPainGlial Cell Line-Derived Neurotrophic Factor Receptors

Stichwörter der Autor:innen

glial-cell-line-derived neurotrophic factor family ligandshumanintervertebral disc degeneration

Substanzen

Glial Cell Line-Derived Neurotrophic FactorTransforming Growth Factor betaRNA, MessengerGFRA4 protein, humanGlial Cell Line-Derived Neurotrophic Factor Receptors

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City 514-8507, Mie, Japan.

ORCID-Profile: Tatsuya Iwasaki, Koji Akeda, Junichi Yamada

Zitieren

APA

Iwasaki, T., Akeda, K., Kawaguchi, K., Yamada, J., Hasegawa, T., Takegami, N., Fujiwara, T., & Sudo, A. (2023). Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115874

Vancouver

Iwasaki T, Akeda K, Kawaguchi K, Yamada J, Hasegawa T, Takegami N, et al. Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115874

BibTeX
@article{Iwasaki2023,
  author = {Iwasaki, Tatsuya and Akeda, Koji and Kawaguchi, Koki and Yamada, Junichi and Hasegawa, Takahiro and Takegami, Norihiko and Fujiwara, Tatsuhiko and Sudo, Akihiro},
  title = {Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115874}
}
Kostenlos starten →